Sheaff Brock Investment Advisors, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sheaff Brock Investment Advisors, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$49,000
-73.9%
10,000
-66.7%
0.01%
-72.2%
Q2 2018$188,000
-69.4%
30,000
-59.5%
0.02%
-71.9%
Q1 2018$614,000
-24.8%
73,998
-7.5%
0.06%
-39.6%
Q4 2017$816,000
-10.8%
80,000
-20.0%
0.11%
-11.7%
Q3 2017$915,000
+323.6%
100,000
+233.3%
0.12%
+328.6%
Q1 2017$216,00030,0000.03%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,971,014$6,413,0004.42%
SPHERA FUNDS MANAGEMENT LTD. 3,711,454$4,788,0000.66%
Proxima Capital Management, LLC 206,000$266,0000.36%
Nantahala Capital Management 4,610,000$5,947,0000.18%
Alambic Investment Management, L.P. 219,090$283,0000.18%
Wealthstar Advisors, LLC 73,295$95,0000.06%
ALGERT GLOBAL LLC 77,845$100,0000.04%
Western Standard LLC 25,935$33,0000.02%
Allred Capital Management, LLC 24,995$33,0000.02%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$414,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders